Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

102.89
+1.291.27%
Pre-market: 103.000.1100+0.11%09:14 EDT
Volume:650.45K
Turnover:66.78M
Market Cap:5.08B
PE:-17.83
High:103.83
Open:101.13
Low:100.00
Close:101.60
Loading ...
May 02, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Major Issues Report

8-K - Current report
Apr 19, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 16, 2021

Major Issues Report

Axsome Therapeutics, Inc.
Sep 16, 2021

Major Issues Report

8-K - Current report